To further clarify the regulation exerted by MRPS16 and NFATC2 on the proliferation of glioma cells in vivo, U87 cells were injected into the brain of BABL/c mice, and the time of maintenance was more than about 7 weeks. The gene discussed is NFATC2; the disease is central nervous system cancer.